Antibody reactivity against the newly-identified INS-IGF2 protein is associated with psychotic symptomatology in patients with schizophrenia or related psychosis

Neuroscience Applied 2026 Open access

Read full text

Authors: K. Melkersson

DOI: 10.1016/j.nsa.2025.105794

Cited by: 0

Fields of Study & Subjects

Tryptophan and brain disorders Schizophrenia research and treatment Growth Hormone and Insulin-like Growth Factors